Use access key #2 to skip to page content.
$73.03 0.57 (0.79%)
7/3/2008 1:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

1

Avatar picks007 (25.15) Submitted: 12/05/06 11:17 PM : Outperform Start Price: $62.87 GENZ Score: 26.25

lowest price in months, time for a bounce back for year's end

Report this Post Replies: 0 | Reply

Featured Broker Partners